Medicines Formulary

Reports

Drug name	NICE TAs	Comments
Granisetron patch		For use in oncology patients only
Granisetron tablets
Grass and tree pollen extract (Pollinex)		Hospital only
Guanfacine (Intuniv®)		2nd line Atomoxetine, hospitals to manage/support patient. For the treatment of ADHD in children and adolescents 6-17 years old for whom stimulants are not suitable, not tolerated or have been shown to be ineffective.
Guselkumab	TA711 - Guselkumab for treating active psoriatic arthritis after inadequate response to DMARDs
Haem arginate (Normasang)		NHSE commissioned.
Heparin sodium injection		Hospital use only
Heparinoid 0.3% cream
Hepatitis B
Histoacryl blue

First page
Previous page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
Next page
Last page

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.